When
Recent
The excessive translational failure rates of pre-clinical laboratory animal model studies calls for alternative approaches which can better inform on the development of biomedical innovations. Compared to laboratory animals, companion dogs are a phenotypically diverse population which naturally develop neoplastic, cardiovascular, infectious, metabolic, neurological, orthopedic, and autoimmune diseases with similarity to humans.
This symposium focuses on the increasingly important role of dogs and veterinary clinical studies in the development of drugs, biologics, diagnostics and devices with parallel applications for human and veterinary medicine. This is a free in-person event for academic researchers, healthcare professionals, veterinarians, students, industry professionals and others focused on translational research and development of biomedical products. This event is graciously supported by a grant from the Arizona Biomedical Research Centre and hosted by The Institute for Future Health, a joint venture between Arizona State University and the University of Arizona.

Leveraging naturally occurring canine diseases to accelerate biomedical innovations for oncology, cardiology, infectious disease and other therapeutic areas.